Encouraging Results Have Been Announced From a Trial of an Investigational Treatment For BPDCN
Results from research into an experimental therapy called SL-401 for the treatment of patients with blastic plasmacytoid dendritic cell neoplasm have been shared at the Congress of the European Haematology…